VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-00748 Package ID: USCOURTS-cofc-1_22-vv-00748 Petitioner: Annalyse Treat Filed: 2022-07-08 Decided: 2024-08-30 Vaccine: influenza Vaccination date: 2019-09-19 Condition: Guillain-Barre Syndrome (GBS) Outcome: compensated Award amount USD: 166589 AI-assisted case summary: Annalyse Treat filed a petition on July 8, 2022, alleging that the influenza vaccine she received on September 19, 2019, caused her to develop Guillain-Barre Syndrome (GBS) and suffer residual effects for more than six months. The influenza vaccine is listed on the Vaccine Injury Table. Respondent denied that the flu vaccine caused GBS or any other injury. Despite the denial, the parties filed a joint stipulation to resolve the case. Special Master Christian J. Moran reviewed the stipulation, found it reasonable, and adopted it as the Court's decision. Ms. Treat was awarded a lump sum of $166,589.92, payable by check to petitioner, as compensation for all damages available under 42 U.S.C. § 300aa-15(a). This award was made on August 30, 2024, concluding the case. Petitioner was represented by Leigh Finfer of Muller Brazil, LLP, and Respondent was represented by Lynn Christina Schlie of the United States Department of Justice. The public decision was issued on August 30, 2024. Theory of causation field: Petitioner Annalyse Treat alleged that the influenza vaccine administered on September 19, 2019, caused Guillain-Barre Syndrome (GBS) and residual effects lasting more than six months. The influenza vaccine is listed on the Vaccine Injury Table, and the petitioner claimed a Table injury. Respondent denied causation. The parties resolved the matter via joint stipulation, which Special Master Christian J. Moran found reasonable and adopted. The stipulation resulted in a lump sum award of $166,589.92 to petitioner. Petitioner was represented by Leigh Finfer (Muller Brazil, LLP), and Respondent by Lynn Christina Schlie (U.S. Department of Justice). The decision was issued on August 30, 2024. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_22-vv-00748-0 Date issued/filed: 2024-08-30 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 08/08/2024) regarding 38 DECISION Stipulation/Proffer. Signed by Special Master Christian J. Moran. (ceo) Service on parties made. -------------------------------------------------------------------------------- Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS * * * * * * * * * * * * * * * * * * * * * * * * * ANNALYSE TREAT, * No. 22-748V * * Petitioner, * * Special Master Christian J. Moran v. * * Filed: August 8, 2024 SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * Leigh Finfer, Muller Brazil, LLP, Dresher, PA, for Petitioner; Lynn Christina Schlie, United States Dep’t of Justice, Washington, DC, for Respondent. UNPUBLISHED DECISION1 On August 6, 2024, the parties filed a joint stipulation concerning the petition for compensation filed by Annalyse Treat on July 8, 2022 Petitioner alleged that the influenza vaccine she received on September 19, 2019, which is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. §100.3(a), caused her to suffer from Guillain-Barre Syndrome (“GBS”). Petitioner further alleges that she suffered the residual effects of this injury for more than six months. Petitioner represents that there has been no prior award or settlement of a civil action for damages on her behalf as a result of her condition. 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), the parties have 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. Any changes will appear in the document posted on the website. Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 2 of 7 Respondent denies that the flu vaccine caused petitioner to suffer GBS, and further denies that the vaccine caused her to suffer any other injury or her current condition. Nevertheless, the parties agree to the joint stipulation, attached hereto. The undersigned finds said stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. Damages awarded in that stipulation include: A lump sum of $166,589.92 in the form of a check payable to petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). In the absence of a motion for review filed pursuant to RCFC, Appendix B, the clerk is directed to enter judgment according to this decision and the attached stipulation.2 IT IS SO ORDERED. s/Christian J. Moran Christian J. Moran Special Master 2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each party filing a notice renouncing the right to seek review by a United States Court of Federal Claims judge. 2 Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 3 of 7 Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 4 of 7 Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 5 of 7 Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 6 of 7 Case 1:22-vv-00748-UNJ Document 42 Filed 08/30/24 Page 7 of 7